IE61562B1 - Azelastine-containing medicaments for application in the nose and/or on the eye - Google Patents

Azelastine-containing medicaments for application in the nose and/or on the eye

Info

Publication number
IE61562B1
IE61562B1 IE340388A IE340388A IE61562B1 IE 61562 B1 IE61562 B1 IE 61562B1 IE 340388 A IE340388 A IE 340388A IE 340388 A IE340388 A IE 340388A IE 61562 B1 IE61562 B1 IE 61562B1
Authority
IE
Ireland
Prior art keywords
azelastine
weight
solution
physiologically acceptable
pharmaceutical preparation
Prior art date
Application number
IE340388A
Other languages
English (en)
Other versions
IE883403L (en
Inventor
Helmut Hettche
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340483&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE61562(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IE883403L publication Critical patent/IE883403L/en
Publication of IE61562B1 publication Critical patent/IE61562B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IE340388A 1987-11-13 1988-11-11 Azelastine-containing medicaments for application in the nose and/or on the eye IE61562B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3738681 1987-11-13

Publications (2)

Publication Number Publication Date
IE883403L IE883403L (en) 1989-05-13
IE61562B1 true IE61562B1 (en) 1994-11-16

Family

ID=6340483

Family Applications (1)

Application Number Title Priority Date Filing Date
IE340388A IE61562B1 (en) 1987-11-13 1988-11-11 Azelastine-containing medicaments for application in the nose and/or on the eye

Country Status (15)

Country Link
US (1) US5164194A (OSRAM)
EP (1) EP0316633B1 (OSRAM)
JP (3) JP2911460B2 (OSRAM)
AT (1) ATE84968T1 (OSRAM)
AU (1) AU613107B2 (OSRAM)
CA (1) CA1319322C (OSRAM)
DE (1) DE3877904D1 (OSRAM)
DK (1) DK174928B1 (OSRAM)
ES (1) ES2053678T3 (OSRAM)
GR (1) GR3007202T3 (OSRAM)
IE (1) IE61562B1 (OSRAM)
NL (1) NL990011I1 (OSRAM)
PT (1) PT88985B (OSRAM)
YU (1) YU46988B (OSRAM)
ZA (1) ZA888461B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051726T3 (es) * 1987-01-17 1994-07-01 Asta Medica Ag Procedimiento para preparar productos inyectables que contienen azelastin y teofilina o azelastin y beta-mimeticos.
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
DE20009841U1 (de) * 2000-05-31 2001-10-25 Phyt-Immun GmbH, 66424 Homburg Nasensalbe auf Basis von Vaselin
JP3450805B2 (ja) 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
WO2002056876A2 (en) * 2001-01-18 2002-07-25 Medpointe Healthcare Inc. Treatment for snoring
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP2295062B1 (en) 2002-08-30 2012-08-29 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP2007501251A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤化合物を使用する感染予防
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PT2486942T (pt) 2004-11-24 2019-01-18 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US7378082B1 (en) * 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
MX2010006932A (es) * 2007-12-21 2010-10-05 Schering Plough Healthcare Aumento de la fotoestabilizacion de la oximetazolina.
US8642069B2 (en) * 2008-08-27 2014-02-04 Alexander D. Goldin Composition and method for treating colds
KR101261230B1 (ko) 2010-11-29 2013-05-07 한림제약(주) 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
KR101943490B1 (ko) 2013-03-13 2019-04-17 플랫틀리 디스커버리 랩, 엘엘씨 피리다지논 화합물 및 낭성 섬유증을 치료하는 방법
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
HUE060929T2 (hu) * 2020-05-29 2023-04-28 CEBINA GmbH Azelasztin, mint antivirális kezelés
CN115701988A (zh) 2020-06-15 2023-02-14 阿尔克姆实验室有限公司 阿卡他定和皮质类固醇的组合
BR112023019795A2 (pt) 2021-04-01 2023-11-07 Alkem Laboratories Ltd Composições nasais compreendendo alcaftadina

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US158564A (en) * 1875-01-12 Improvement in medicine-droppers
US2119643A (en) * 1934-11-07 1938-06-07 Mendl Viktor Pressure-operated diffuser of toilet-liquids
US2136940A (en) * 1936-07-02 1938-11-15 Aromel Corp Atomizer
US2457024A (en) * 1945-02-13 1948-12-21 Arp Claus Collapsible tube holder
US2995308A (en) * 1958-09-23 1961-08-08 American Home Prod Jet stream dispenser
CH572914A5 (OSRAM) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate
US4769369A (en) * 1986-11-14 1988-09-06 Pennwalt Corporation Anti-allergy 1(2H)-phthalazinones
JP6034925B2 (ja) 2015-07-07 2016-11-30 株式会社ブリヂストン 接着剤組成物、接着剤被覆繊維、ゴム物品及び空気入りタイヤ

Also Published As

Publication number Publication date
YU209288A (en) 1990-04-30
JP2911460B2 (ja) 1999-06-23
AU613107B2 (en) 1991-07-25
DK174928B1 (da) 2004-03-01
JP2956029B2 (ja) 1999-10-04
NL990011I1 (nl) 1999-07-01
US5164194A (en) 1992-11-17
JPH01153639A (ja) 1989-06-15
DK630188D0 (da) 1988-11-11
DE3877904D1 (de) 1993-03-11
IE883403L (en) 1989-05-13
YU46988B (sh) 1994-09-09
ATE84968T1 (de) 1993-02-15
GR3007202T3 (OSRAM) 1993-07-30
ZA888461B (en) 1989-08-30
ES2053678T3 (es) 1994-08-01
EP0316633A1 (de) 1989-05-24
PT88985A (pt) 1988-12-01
JPH11349484A (ja) 1999-12-21
JPH10182464A (ja) 1998-07-07
EP0316633B1 (de) 1993-01-27
JP3207816B2 (ja) 2001-09-10
AU2506388A (en) 1989-05-18
DK630188A (da) 1989-05-14
PT88985B (pt) 1993-01-29
CA1319322C (en) 1993-06-22

Similar Documents

Publication Publication Date Title
IE61562B1 (en) Azelastine-containing medicaments for application in the nose and/or on the eye
KR100211479B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제
RU2361593C2 (ru) Комбинация азеластина и стероидов
EP1100465A1 (de) Medizinische aerosolformulierungen
WO2007126865A2 (en) Leukotriene antagonists via nasal drug delivery
WO2002056876A2 (en) Treatment for snoring
EP0370632B1 (en) Pharmaceutical solution containing salbutamol and cromoglycic acid
US4385048A (en) Methods for the treatment of nasal hypersecretion
GB2162745A (en) Nasal compositions
JP2001048780A (ja) ビタミン類水溶液の安定化方法及び安定な液状ビタミン製剤
ITMI20011389A1 (it) Formulazioni farmaceutiche acquose di cromoglicato sodico
AU2001282521B2 (en) OCT preparations
DE3836579A1 (de) Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge
EP0212927B1 (en) Pharmaceutical composition comprising sodium cromoglycate and a mucolytic agent
SI8812092A (sl) Postopek za proizvodnjo zdravilnih preparatov, ki vsebujejo azelastin za uporabo v nosu in/ali v očesu
WO2005053672A1 (ja) シロミラストまたはその塩を有効成分とする掻痒治療剤
NO179102B (no) 3-[2-(dimetylamino)etylÅ-N-metyl-1H-indol-5-metansulfonamid

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 23/98, 19981210

SPCG Supplementary protection certificate granted

Free format text: SPC023/98: 20040415, EXPIRES: 20130217

Spc suppl protection certif: SPC023/98

Filing date: 20040415

Expiry date: 20130217

MK9A Patent expired